These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3231623)

  • 1. [Chemotherapy of experimental mycobacteriosis].
    Aleksandrova AE; Lozovskaia ME; Ariel' BM; Otten TF
    Probl Tuberk; 1988; (9):47-52. PubMed ID: 3231623
    [No Abstract]   [Full Text] [Related]  

  • 2. Some healthy skepticism about inhaled therapy for tuberculosis.
    Iseman MD
    Clin Infect Dis; 2001 Jul; 33(2):266-7. PubMed ID: 11418891
    [No Abstract]   [Full Text] [Related]  

  • 3. [Relationship between the susceptibility testing of Mycobacterium avium complex strains and the clinical efficacy of antituberculosis drugs--an evidence suggesting that antituberculosis drugs are effective in the treatment of M. avium complex pulmonary infection].
    Tsukamura M; Ichiyama S; Miyachi T
    Kekkaku; 1988 Apr; 63(4):227-31. PubMed ID: 3404801
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experimental tuberculosis in mice, a model for the study of antitubercular chemotherapy].
    Rist N
    Arch Roum Pathol Exp Microbiol; 1971 Jun; 30(2):295-6. PubMed ID: 5004388
    [No Abstract]   [Full Text] [Related]  

  • 5. [Possibility of the intensification of tuberculosis chemotherapy and its limits].
    Naito M; Kanai K; Kondo E; Yamashita H; Matsui K
    Kekkaku; 1969 Nov; 44(11):377-93. PubMed ID: 4982567
    [No Abstract]   [Full Text] [Related]  

  • 6. Activity of capuramycin analogues against Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellulare in vitro and in vivo.
    Koga T; Fukuoka T; Doi N; Harasaki T; Inoue H; Hotoda H; Kakuta M; Muramatsu Y; Yamamura N; Hoshi M; Hirota T
    J Antimicrob Chemother; 2004 Oct; 54(4):755-60. PubMed ID: 15347635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The bacteriology of tuberculosis and non-tuberculosis mycobacterial infections].
    Wyplosz B; Truffot-Pernot C; Robert J; Jarlier V; Grosset J
    Rev Mal Respir; 1997 Dec; 14 Suppl 5():S33-48. PubMed ID: 9496590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individualized therapy versus standard regimens in the treatment of Mycobacterium avium infections.
    Heifets LB; Iseman MD
    Am Rev Respir Dis; 1991 Jul; 144(1):1-2. PubMed ID: 2064112
    [No Abstract]   [Full Text] [Related]  

  • 9. Bacteriologic basis of short-course chemotherapy for tuberculosis.
    Grosset J
    Clin Chest Med; 1980 May; 1(2):231-41. PubMed ID: 6794976
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemotherapy of chronic pulmonary tuberculosis with polyresistant bacteria with reference to ethambutol and capreomycin.
    Radenbach KL
    Scand J Respir Dis Suppl; 1968; 65():195-206. PubMed ID: 4978461
    [No Abstract]   [Full Text] [Related]  

  • 11. Disseminated infection with Mycobacterium avium: I. Clinical features, treatment and pathology.
    Schonell ME; Crofton JW; Stuart AE; Wallace A
    Tubercle; 1968 Mar; 49(1):12-30. PubMed ID: 4969143
    [No Abstract]   [Full Text] [Related]  

  • 12. [Efficacy of chemotherapy of pulmonary tuberculosis drug-resistant m.tuberculosis].
    Khomenko AG; Chukanov VI; Korneev AA
    Probl Tuberk; 1996; (6):42-4. PubMed ID: 9019768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical course and chemotherapy of hyperchronic destructive pulmonary tuberculosis].
    Mamolat AS; Bialik IB; Khutorskaia VD
    Probl Tuberk; 1985; (10):24-8. PubMed ID: 3934660
    [No Abstract]   [Full Text] [Related]  

  • 14. [Research on primary resistance to antitubercular agents and antibiotics in the antituberculosis centers].
    Santi GM; Poggiopollini M
    Minerva Med; 1967 Jun; 58(49):2285-8. PubMed ID: 6029301
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical study on tuberactinomycin, a new antibiotic].
    Osato T; Toyoara M
    Kekkaku; 1971 May; 46(3):59-63. PubMed ID: 4324041
    [No Abstract]   [Full Text] [Related]  

  • 16. Rifampicin and ethambutol in the treatment of drug resistant and far advanced pulmonary tuberculosis (with a note on capreomycin).
    Pines A; Raafat H; Siddiqui GM
    J Ir Med Assoc; 1970 Mar; 63(393):82-5. PubMed ID: 4984340
    [No Abstract]   [Full Text] [Related]  

  • 17. [2 cases of pulmonary mycobacteriosis].
    Bednarski Z
    Wiad Lek; 1983 Dec; 36(24):2053-6. PubMed ID: 6675318
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on the open negative syndrome resulting from chemotherapy with secondary anti-tuberculosis agents.
    Kimura Y
    Jpn J Tuberc; 1966 Dec; 13():Suppl:71-6. PubMed ID: 5298482
    [No Abstract]   [Full Text] [Related]  

  • 19. Capreomycin and other drugs in the treatment of pulmonary tuberculosis.
    Zierski M
    Tubercle; 1969 Mar; 50():Suppl:37-9. PubMed ID: 4319132
    [No Abstract]   [Full Text] [Related]  

  • 20. [Preclinical study of therapeutic agents used against Mycobacterium avium complex infections--with special reference to new macrolides and new quinolones].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1996 Sep; 71(9):531-5. PubMed ID: 8999135
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.